 | • レポートコード：MRC2-11QY12013 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はゴーシェ病治療のグローバル市場について調査・分析したレポートです。種類別（1型（神経障害性フォーム）、2型（周産期致死フォーム）、3型（遅神経性崩壊フォーム））市場規模、用途別（病院、外来手術センター、臨床研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ゴーシェ病治療の競争状況、市場シェア ・世界のゴーシェ病治療市場：種類別市場規模 2015年-2020年（1型（神経障害性フォーム）、2型（周産期致死フォーム）、3型（遅神経性崩壊フォーム）） ・世界のゴーシェ病治療市場：種類別市場規模予測 2021年-2026年（1型（神経障害性フォーム）、2型（周産期致死フォーム）、3型（遅神経性崩壊フォーム）） ・世界のゴーシェ病治療市場：用途別市場規模 2015年-2020年（病院、外来手術センター、臨床研究所） ・世界のゴーシェ病治療市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、臨床研究所） ・北米のゴーシェ病治療市場分析：米国、カナダ ・ヨーロッパのゴーシェ病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのゴーシェ病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のゴーシェ病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのゴーシェ病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Aptalis Pharma、Genzyme Corporation、GlaxoSmithKline (GSK)、Pfizer Inc、Shire Human Genetic Therapies、Eli Lilly and Company、Enobia Pharma Inc、Anthera Pharmaceuticals、BioMarin Pharmaceutical、MedPro Rx、Zymenex A/S ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Gaucher Disease Treatment Market
The global Gaucher Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Gaucher Disease Treatment Scope and Market Size
Gaucher Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gaucher Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Aptalis Pharma
Genzyme Corporation
GlaxoSmithKline (GSK)
Pfizer Inc
Shire Human Genetic Therapies
Eli Lilly and Company
Enobia Pharma Inc
Anthera Pharmaceuticals
BioMarin Pharmaceutical
MedPro Rx
Zymenex A/S
Market segment by Type, the product can be split into
Type 1 (Neuropathic Forms)
Type 2 (Perinatal Lethal Form)
Type 3 (Slow-neurologic Decay Form)
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Clinical Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gaucher Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Gaucher Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Type 1 (Neuropathic Forms)
1.4.3 Type 2 (Perinatal Lethal Form)
1.4.4 Type 3 (Slow-neurologic Decay Form)
1.5 Market by Application
1.5.1 Global Gaucher Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinical Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Gaucher Disease Treatment Market Perspective (2015-2026)
2.2 Global Gaucher Disease Treatment Growth Trends by Regions
2.2.1 Gaucher Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gaucher Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Gaucher Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gaucher Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Gaucher Disease Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Gaucher Disease Treatment Players by Market Size
3.1.1 Global Top Gaucher Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Gaucher Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Gaucher Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gaucher Disease Treatment Market Concentration Ratio
3.2.1 Global Gaucher Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gaucher Disease Treatment Revenue in 2019
3.3 Gaucher Disease Treatment Key Players Head office and Area Served
3.4 Key Players Gaucher Disease Treatment Product Solution and Service
3.5 Date of Enter into Gaucher Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gaucher Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Gaucher Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Gaucher Disease Treatment Market Size by Application (2015-2020)
5.2 Global Gaucher Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gaucher Disease Treatment Market Size (2015-2020)
6.2 Gaucher Disease Treatment Key Players in North America (2019-2020)
6.3 North America Gaucher Disease Treatment Market Size by Type (2015-2020)
6.4 North America Gaucher Disease Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gaucher Disease Treatment Market Size (2015-2020)
7.2 Gaucher Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Gaucher Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Gaucher Disease Treatment Market Size by Application (2015-2020)
8 China
8.1 China Gaucher Disease Treatment Market Size (2015-2020)
8.2 Gaucher Disease Treatment Key Players in China (2019-2020)
8.3 China Gaucher Disease Treatment Market Size by Type (2015-2020)
8.4 China Gaucher Disease Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gaucher Disease Treatment Market Size (2015-2020)
9.2 Gaucher Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Gaucher Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Gaucher Disease Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gaucher Disease Treatment Market Size (2015-2020)
10.2 Gaucher Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gaucher Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Gaucher Disease Treatment Market Size by Application (2015-2020)
11 India
11.1 India Gaucher Disease Treatment Market Size (2015-2020)
11.2 Gaucher Disease Treatment Key Players in India (2019-2020)
11.3 India Gaucher Disease Treatment Market Size by Type (2015-2020)
11.4 India Gaucher Disease Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gaucher Disease Treatment Market Size (2015-2020)
12.2 Gaucher Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Gaucher Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Gaucher Disease Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Gaucher Disease Treatment Introduction
13.1.4 Abbott Revenue in Gaucher Disease Treatment Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Aptalis Pharma
13.2.1 Aptalis Pharma Company Details
13.2.2 Aptalis Pharma Business Overview
13.2.3 Aptalis Pharma Gaucher Disease Treatment Introduction
13.2.4 Aptalis Pharma Revenue in Gaucher Disease Treatment Business (2015-2020)
13.2.5 Aptalis Pharma Recent Development
13.3 Genzyme Corporation
13.3.1 Genzyme Corporation Company Details
13.3.2 Genzyme Corporation Business Overview
13.3.3 Genzyme Corporation Gaucher Disease Treatment Introduction
13.3.4 Genzyme Corporation Revenue in Gaucher Disease Treatment Business (2015-2020)
13.3.5 Genzyme Corporation Recent Development
13.4 GlaxoSmithKline (GSK)
13.4.1 GlaxoSmithKline (GSK) Company Details
13.4.2 GlaxoSmithKline (GSK) Business Overview
13.4.3 GlaxoSmithKline (GSK) Gaucher Disease Treatment Introduction
13.4.4 GlaxoSmithKline (GSK) Revenue in Gaucher Disease Treatment Business (2015-2020)
13.4.5 GlaxoSmithKline (GSK) Recent Development
13.5 Pfizer Inc
13.5.1 Pfizer Inc Company Details
13.5.2 Pfizer Inc Business Overview
13.5.3 Pfizer Inc Gaucher Disease Treatment Introduction
13.5.4 Pfizer Inc Revenue in Gaucher Disease Treatment Business (2015-2020)
13.5.5 Pfizer Inc Recent Development
13.6 Shire Human Genetic Therapies
13.6.1 Shire Human Genetic Therapies Company Details
13.6.2 Shire Human Genetic Therapies Business Overview
13.6.3 Shire Human Genetic Therapies Gaucher Disease Treatment Introduction
13.6.4 Shire Human Genetic Therapies Revenue in Gaucher Disease Treatment Business (2015-2020)
13.6.5 Shire Human Genetic Therapies Recent Development
13.7 Eli Lilly and Company
13.7.1 Eli Lilly and Company Company Details
13.7.2 Eli Lilly and Company Business Overview
13.7.3 Eli Lilly and Company Gaucher Disease Treatment Introduction
13.7.4 Eli Lilly and Company Revenue in Gaucher Disease Treatment Business (2015-2020)
13.7.5 Eli Lilly and Company Recent Development
13.8 Enobia Pharma Inc
13.8.1 Enobia Pharma Inc Company Details
13.8.2 Enobia Pharma Inc Business Overview
13.8.3 Enobia Pharma Inc Gaucher Disease Treatment Introduction
13.8.4 Enobia Pharma Inc Revenue in Gaucher Disease Treatment Business (2015-2020)
13.8.5 Enobia Pharma Inc Recent Development
13.9 Anthera Pharmaceuticals
13.9.1 Anthera Pharmaceuticals Company Details
13.9.2 Anthera Pharmaceuticals Business Overview
13.9.3 Anthera Pharmaceuticals Gaucher Disease Treatment Introduction
13.9.4 Anthera Pharmaceuticals Revenue in Gaucher Disease Treatment Business (2015-2020)
13.9.5 Anthera Pharmaceuticals Recent Development
13.10 BioMarin Pharmaceutical
13.10.1 BioMarin Pharmaceutical Company Details
13.10.2 BioMarin Pharmaceutical Business Overview
13.10.3 BioMarin Pharmaceutical Gaucher Disease Treatment Introduction
13.10.4 BioMarin Pharmaceutical Revenue in Gaucher Disease Treatment Business (2015-2020)
13.10.5 BioMarin Pharmaceutical Recent Development
13.11 MedPro Rx
10.11.1 MedPro Rx Company Details
10.11.2 MedPro Rx Business Overview
10.11.3 MedPro Rx Gaucher Disease Treatment Introduction
10.11.4 MedPro Rx Revenue in Gaucher Disease Treatment Business (2015-2020)
10.11.5 MedPro Rx Recent Development
13.12 Zymenex A/S
10.12.1 Zymenex A/S Company Details
10.12.2 Zymenex A/S Business Overview
10.12.3 Zymenex A/S Gaucher Disease Treatment Introduction
10.12.4 Zymenex A/S Revenue in Gaucher Disease Treatment Business (2015-2020)
10.12.5 Zymenex A/S Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Gaucher Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Gaucher Disease Treatment Revenue
Table 3. Ranking of Global Top Gaucher Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gaucher Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Type 1 (Neuropathic Forms)
Table 6. Key Players of Type 2 (Perinatal Lethal Form)
Table 7. Key Players of Type 3 (Slow-neurologic Decay Form)
Table 8. Global Gaucher Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Gaucher Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Gaucher Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Gaucher Disease Treatment Market Share by Regions (2015-2020)
Table 12. Global Gaucher Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Gaucher Disease Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Gaucher Disease Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Gaucher Disease Treatment Players
Table 19. Global Gaucher Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Gaucher Disease Treatment Market Share by Players (2015-2020)
Table 21. Global Top Gaucher Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher Disease Treatment as of 2019)
Table 22. Global Gaucher Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Gaucher Disease Treatment Product Solution and Service
Table 25. Date of Enter into Gaucher Disease Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Gaucher Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Gaucher Disease Treatment Market Size Share by Type (2015-2020)
Table 29. Global Gaucher Disease Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Gaucher Disease Treatment Market Size Share by Application (2015-2020)
Table 31. Global Gaucher Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Gaucher Disease Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Gaucher Disease Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Gaucher Disease Treatment Market Share (2019-2020)
Table 35. North America Gaucher Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Gaucher Disease Treatment Market Share by Type (2015-2020)
Table 37. North America Gaucher Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Gaucher Disease Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Gaucher Disease Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Gaucher Disease Treatment Market Share (2019-2020)
Table 41. Europe Gaucher Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Gaucher Disease Treatment Market Share by Type (2015-2020)
Table 43. Europe Gaucher Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Gaucher Disease Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Gaucher Disease Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Gaucher Disease Treatment Market Share (2019-2020)
Table 47. China Gaucher Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Gaucher Disease Treatment Market Share by Type (2015-2020)
Table 49. China Gaucher Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Gaucher Disease Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Gaucher Disease Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Gaucher Disease Treatment Market Share (2019-2020)
Table 53. Japan Gaucher Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Gaucher Disease Treatment Market Share by Type (2015-2020)
Table 55. Japan Gaucher Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Gaucher Disease Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Gaucher Disease Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Gaucher Disease Treatment Market Share (2019-2020)
Table 59. Southeast Asia Gaucher Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Gaucher Disease Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Gaucher Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Gaucher Disease Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Gaucher Disease Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Gaucher Disease Treatment Market Share (2019-2020)
Table 65. India Gaucher Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Gaucher Disease Treatment Market Share by Type (2015-2020)
Table 67. India Gaucher Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Gaucher Disease Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Gaucher Disease Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Gaucher Disease Treatment Market Share (2019-2020)
Table 71. Central & South America Gaucher Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Gaucher Disease Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Gaucher Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Gaucher Disease Treatment Market Share by Application (2015-2020)
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Product
Table 78. Abbott Revenue in Gaucher Disease Treatment Business (2015-2020) (Million US$)
Table 79. Abbott Recent Development
Table 80. Aptalis Pharma Company Details
Table 81. Aptalis Pharma Business Overview
Table 82. Aptalis Pharma Product
Table 83. Aptalis Pharma Revenue in Gaucher Disease Treatment Business (2015-2020) (Million US$)
Table 84. Aptalis Pharma Recent Development
Table 85. Genzyme Corporation Company Details
Table 86. Genzyme Corporation Business Overview
Table 87. Genzyme Corporation Product
Table 88. Genzyme Corporation Revenue in Gaucher Disease Treatment Business (2015-2020) (Million US$)
Table 89. Genzyme Corporation Recent Development
Table 90. GlaxoSmithKline (GSK) Company Details
Table 91. GlaxoSmithKline (GSK) Business Overview
Table 92. GlaxoSmithKline (GSK) Product
Table 93. GlaxoSmithKline (GSK) Revenue in Gaucher Disease Treatment Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline (GSK) Recent Development
Table 95. Pfizer Inc Company Details
Table 96. Pfizer Inc Business Overview
Table 97. Pfizer Inc Product
Table 98. Pfizer Inc Revenue in Gaucher Disease Treatment Business (2015-2020) (Million US$)
Table 99. Pfizer Inc Recent Development
Table 100. Shire Human Genetic Therapies Company Details
Table 101. Shire Human Genetic Therapies Business Overview
Table 102. Shire Human Genetic Therapies Product
Table 103. Shire Human Genetic Therapies Revenue in Gaucher Disease Treatment Business (2015-2020) (Million US$)
Table 104. Shire Human Genetic Therapies Recent Development
Table 105. Eli Lilly and Company Company Details
Table 106. Eli Lilly and Company Business Overview
Table 107. Eli Lilly and Company Product
Table 108. Eli Lilly and Company Revenue in Gaucher Disease Treatment Business (2015-2020) (Million US$)
Table 109. Eli Lilly and Company Recent Development
Table 110. Enobia Pharma Inc Business Overview
Table 111. Enobia Pharma Inc Product
Table 112. Enobia Pharma Inc Company Details
Table 113. Enobia Pharma Inc Revenue in Gaucher Disease Treatment Business (2015-2020) (Million US$)
Table 114. Enobia Pharma Inc Recent Development
Table 115. Anthera Pharmaceuticals Company Details
Table 116. Anthera Pharmaceuticals Business Overview
Table 117. Anthera Pharmaceuticals Product
Table 118. Anthera Pharmaceuticals Revenue in Gaucher Disease Treatment Business (2015-2020) (Million US$)
Table 119. Anthera Pharmaceuticals Recent Development
Table 120. BioMarin Pharmaceutical Company Details
Table 121. BioMarin Pharmaceutical Business Overview
Table 122. BioMarin Pharmaceutical Product
Table 123. BioMarin Pharmaceutical Revenue in Gaucher Disease Treatment Business (2015-2020) (Million US$)
Table 124. BioMarin Pharmaceutical Recent Development
Table 125. MedPro Rx Company Details
Table 126. MedPro Rx Business Overview
Table 127. MedPro Rx Product
Table 128. MedPro Rx Revenue in Gaucher Disease Treatment Business (2015-2020) (Million US$)
Table 129. MedPro Rx Recent Development
Table 130. Zymenex A/S Company Details
Table 131. Zymenex A/S Business Overview
Table 132. Zymenex A/S Product
Table 133. Zymenex A/S Revenue in Gaucher Disease Treatment Business (2015-2020) (Million US$)
Table 134. Zymenex A/S Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gaucher Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Type 1 (Neuropathic Forms) Features
Figure 3. Type 2 (Perinatal Lethal Form) Features
Figure 4. Type 3 (Slow-neurologic Decay Form) Features
Figure 5. Global Gaucher Disease Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Clinical Research Institutes Case Studies
Figure 9. Gaucher Disease Treatment Report Years Considered
Figure 10. Global Gaucher Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Gaucher Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Gaucher Disease Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Gaucher Disease Treatment Market Share by Players in 2019
Figure 15. Global Top Gaucher Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher Disease Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Gaucher Disease Treatment Revenue in 2019
Figure 17. North America Gaucher Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Gaucher Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Gaucher Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Gaucher Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Gaucher Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Gaucher Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Gaucher Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
ゴーシェ病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Gaucher Disease Drugs Market The global Gaucher Disease Drugs market size is projected to reach US$ 1330 million by 2026, from US$ 1321 million in 2020, at a CAGR of 0.6%% during 2021-2026. Global Gaucher Disease Drugs Scope and Market Size Gaucher Disease Drugs …- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…
- キャッスルマン病治療の世界市場（～2026年） Castleman disease is a rare condition of lymph nodes and similar tissues. This condition occurs when too many non-cancer cells started to grow in the lymph node. After initial growth hard growth started to form. Usually, it occurs in the chest, abdomen or neck. This condition is also called as angio…
- 感染症治療の世界市場（～2026年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…